{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:49:54Z","timestamp":1792698594298,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,11,13]],"date-time":"2022-11-13T00:00:00Z","timestamp":1668297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,13]],"date-time":"2022-11-13T00:00:00Z","timestamp":1668297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s00415-022-11474-4","type":"journal-article","created":{"date-parts":[[2022,11,13]],"date-time":"2022-11-13T19:02:48Z","timestamp":1668366168000},"page":"1178-1186","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Optical coherence tomography as a prognostic tool for disability progression in MS: a systematic review"],"prefix":"10.1007","volume":"270","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1028-197X","authenticated-orcid":false,"given":"Stijn","family":"Swinnen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dries","family":"De Wit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liesbeth","family":"Van Cleemput","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Cassiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0604-8702","authenticated-orcid":false,"given":"B\u00e9n\u00e9dicte","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,13]]},"reference":[{"issue":"2","key":"11474_CR1","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1056\/NEJMra1401483","volume":"378","author":"DS Reich","year":"2018","unstructured":"Reich DS, Lucchinetti CF, Calabresi PA (2018) Multiple sclerosis. N Engl J Med 378(2):169\u2013180","journal-title":"N Engl J Med"},{"issue":"3","key":"11474_CR2","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/ana.21423","volume":"64","author":"LK Fisniku","year":"2008","unstructured":"Fisniku LK et al (2008) Gray matter atrophy is related to long-term disability in multiple sclerosis. Ann Neurol 64(3):247\u2013254","journal-title":"Ann Neurol"},{"issue":"4","key":"11474_CR3","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nrneurol.2014.37","volume":"10","author":"MA Friese","year":"2014","unstructured":"Friese MA, Schattling B, Fugger L (2014) Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis. Nat Rev Neurol 10(4):225\u2013238","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"11474_CR4","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/S1474-4422(06)70349-0","volume":"5","author":"RA Bermel","year":"2006","unstructured":"Bermel RA, Bakshi R (2006) The measurement and clinical relevance of brain atrophy in multiple sclerosis. Lancet Neurol 5(2):158\u2013170","journal-title":"Lancet Neurol"},{"issue":"3","key":"11474_CR5","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41582-020-0314-x","volume":"16","author":"J Sastre-Garriga","year":"2020","unstructured":"Sastre-Garriga J et al (2020) MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice. Nat Rev Neurol 16(3):171\u2013182","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"11474_CR6","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1093\/brain\/awq080","volume":"133","author":"AJ Green","year":"2010","unstructured":"Green AJ et al (2010) Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration. Brain 133(6):1591\u20131601","journal-title":"Brain"},{"issue":"10","key":"11474_CR7","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S1474-4422(17)30278-8","volume":"16","author":"A Petzold","year":"2017","unstructured":"Petzold A et al (2017) Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol 16(10):797\u2013812","journal-title":"Lancet Neurol"},{"issue":"1","key":"11474_CR8","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/ana.24030","volume":"75","author":"I Gabilondo","year":"2014","unstructured":"Gabilondo I et al (2014) Trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis. Ann Neurol 75(1):98\u2013107","journal-title":"Ann Neurol"},{"issue":"1","key":"11474_CR9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1177\/1352458516637679","volume":"23","author":"M Petracca","year":"2017","unstructured":"Petracca M et al (2017) Retinal degeneration in primary-progressive multiple sclerosis: a role for cortical lesions? Mult Scler 23(1):43\u201350","journal-title":"Mult Scler"},{"issue":"2","key":"11474_CR10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11910-017-0725-2","volume":"17","author":"M Dinkin","year":"2017","unstructured":"Dinkin M (2017) Trans-synaptic retrograde degeneration in the human visual system: slow, silent, and real. Curr Neurol Neurosci Rep 17(2):16","journal-title":"Curr Neurol Neurosci Rep"},{"key":"11474_CR11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1212\/WNL.0b013e31827b1a1c","volume":"80","author":"JN Ratchford","year":"2013","unstructured":"Ratchford JN et al (2013) Active MS is associated with accelerated retinal ganglion cell\/inner plexiform layer thinning. Neurology 80:47\u201354","journal-title":"Neurology"},{"issue":"1","key":"11474_CR12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/WNO.0000000000000057","volume":"34","author":"JM Abalo-Lojo","year":"2014","unstructured":"Abalo-Lojo JM et al (2014) Retinal nerve fiber layer thickness, brain atrophy, and disability in multiple sclerosis patients. J Neuroophthalmol 34(1):23\u201328","journal-title":"J Neuroophthalmol"},{"issue":"5","key":"11474_CR13","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/ana.24487","volume":"78","author":"S Saidha","year":"2015","unstructured":"Saidha S et al (2015) Optical coherence tomography reflects brain atrophy in multiple sclerosis: a four-year study. Ann Neurol 78(5):801\u2013813","journal-title":"Ann Neurol"},{"key":"11474_CR14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.msard.2018.03.007","volume":"22","author":"R Alonso","year":"2018","unstructured":"Alonso R, Gonzalez-Moron D, Garcea O (2018) Optical coherence tomography as a biomarker of neurodegeneration in multiple sclerosis: a review. Mult Scler Relat Disord 22:77\u201382","journal-title":"Mult Scler Relat Disord"},{"issue":"6","key":"11474_CR15","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1177\/1352458519872751","volume":"26","author":"J Lambe","year":"2020","unstructured":"Lambe J, Saidha S, Bermel RA (2020) Optical coherence tomography and multiple sclerosis: update on clinical application and role in clinical trials. Mult Scler 26(6):624\u2013639","journal-title":"Mult Scler"},{"key":"11474_CR16","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jclinepi.2016.01.021","volume":"75","author":"J McGowan","year":"2016","unstructured":"McGowan J et al (2016) PRESS peer review of electronic search strategies: 2015 guideline statement. J Clin Epidemiol 75:40\u201346","journal-title":"J Clin Epidemiol"},{"key":"11474_CR17","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Br Med J (Clin Res Ed) 372:n71","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"1","key":"11474_CR18","doi-asserted-by":"publisher","first-page":"84","DOI":"10.5195\/jmla.2017.111","volume":"105","author":"WM Bramer","year":"2017","unstructured":"Bramer WM, Milic J, Mast F (2017) Reviewing retrieved references for inclusion in systematic reviews using EndNote. J Med Libr Assoc 105(1):84\u201387","journal-title":"J Med Libr Assoc"},{"key":"11474_CR19","doi-asserted-by":"publisher","first-page":"A12","DOI":"10.7326\/ACPJC-1995-123-3-A12","volume":"123","author":"WS Richardson","year":"1995","unstructured":"Richardson WS et al (1995) The well-built clinical question: a key to evidence-based decisions. ACP J Club 123:A12","journal-title":"ACP J Club"},{"key":"11474_CR20","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1002\/ana.20703","volume":"58","author":"CH Polman","year":"2005","unstructured":"Polman CH et al (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201cMcDonald criteria.\u201d Ann Neurol 58:840\u2013846","journal-title":"Ann Neurol"},{"issue":"2","key":"11474_CR21","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH et al (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69(2):292\u2013302","journal-title":"Ann Neurol"},{"issue":"2","key":"11474_CR22","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17(2):162\u2013173","journal-title":"Lancet Neurol"},{"key":"11474_CR23","doi-asserted-by":"publisher","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","volume":"158","author":"JA Hayden","year":"2013","unstructured":"Hayden JA et al (2013) Assessing bias in studies of prognostic factors. Ann Intern Med 158:280\u2013286","journal-title":"Ann Intern Med"},{"key":"11474_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k4597","volume":"364","author":"RD Riley","year":"2019","unstructured":"Riley RD et al (2019) A guide to systematic review and meta-analysis of prognostic factor studies. Br Med J (Clin Res Ed) 364:k4597","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"16","key":"11474_CR25","doi-asserted-by":"publisher","first-page":"e2058","DOI":"10.1212\/WNL.0000000000011788","volume":"96","author":"J Lambe","year":"2021","unstructured":"Lambe J et al (2021) Association of spectral-domain OCT with long-term disability worsening in multiple sclerosis. Neurology 96(16):e2058\u2013e2069","journal-title":"Neurology"},{"issue":"6","key":"11474_CR26","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/S1474-4422(16)00068-5","volume":"15","author":"EH Martinez-Lapiscina","year":"2016","unstructured":"Martinez-Lapiscina EH et al (2016) Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study. Lancet Neurol 15(6):574\u2013584","journal-title":"Lancet Neurol"},{"issue":"2","key":"11474_CR27","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1177\/1352458517740216","volume":"25","author":"G Bsteh","year":"2019","unstructured":"Bsteh G et al (2019) Peripapillary retinal nerve fibre layer as measured by optical coherence tomography is a prognostic biomarker not only for physical but also for cognitive disability progression in multiple sclerosis. Mult Scler 25(2):196\u2013203","journal-title":"Mult Scler"},{"issue":"6","key":"11474_CR28","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1111\/ene.13897","volume":"26","author":"G Bsteh","year":"2019","unstructured":"Bsteh G et al (2019) Peripapillary retinal nerve fibre layer thinning rate as a biomarker discriminating stable and progressing relapsing-remitting multiple sclerosis. Eur J Neurol 26(6):865\u2013871","journal-title":"Eur J Neurol"},{"issue":"5","key":"11474_CR29","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1177\/1352458520935724","volume":"27","author":"G Bsteh","year":"2021","unstructured":"Bsteh G et al (2021) Macular ganglion cell-inner plexiform layer thinning as a biomarker of disability progression in relapsing multiple sclerosis. Mult Scler 27(5):684\u2013694","journal-title":"Mult Scler"},{"issue":"6","key":"11474_CR30","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1111\/ene.14829","volume":"28","author":"G Bsteh","year":"2021","unstructured":"Bsteh G et al (2021) Retinal layer thinning predicts treatment failure in relapsing multiple sclerosis. Eur J Neurol 28(6):2037\u20132045","journal-title":"Eur J Neurol"},{"issue":"8","key":"11474_CR31","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1007\/s00415-021-10469-x","volume":"268","author":"V Cilingir","year":"2021","unstructured":"Cilingir V, Batur M (2021) First measured retinal nerve fiber layer thickness in RRMS can be used as a biomarker for the course of the disease: threshold value discussions. J Neurol 268(8):2858\u20132865","journal-title":"J Neurol"},{"key":"11474_CR32","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2147\/EB.S295610","volume":"13","author":"N Schurz","year":"2021","unstructured":"Schurz N et al (2021) Evaluation of retinal layer thickness parameters as biomarkers in a real-world multiple sclerosis cohort. Eye Brain 13:59\u201369","journal-title":"Eye Brain"},{"issue":"3","key":"11474_CR33","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/ana.24351","volume":"77","author":"I Gabilondo","year":"2015","unstructured":"Gabilondo I et al (2015) Dynamics of retinal injury after acute optic neuritis. Ann Neurol 77(3):517\u2013528","journal-title":"Ann Neurol"},{"issue":"5","key":"11474_CR34","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1177\/1352458515598020","volume":"22","author":"MJ Kupersmith","year":"2016","unstructured":"Kupersmith MJ et al (2016) Retinal ganglion cell layer thinning within one month of presentation for optic neuritis. Mult Scler 22(5):641\u2013648","journal-title":"Mult Scler"},{"issue":"9","key":"11474_CR35","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1007\/s00415-017-8531-y","volume":"264","author":"J Britze","year":"2017","unstructured":"Britze J, Pihl-Jensen G, Frederiksen JL (2017) Retinal ganglion cell analysis in multiple sclerosis and optic neuritis: a systematic review and meta-analysis. J Neurol 264(9):1837\u20131853","journal-title":"J Neurol"},{"issue":"4","key":"11474_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0034823","volume":"7","author":"P Tewarie","year":"2012","unstructured":"Tewarie P et al (2012) The OSCAR-IB consensus criteria for retinal OCT quality assessment. PLoS ONE 7(4):e34823","journal-title":"PLoS ONE"},{"issue":"2","key":"11474_CR37","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1177\/1352458514538110","volume":"21","author":"S Schippling","year":"2015","unstructured":"Schippling S et al (2015) Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria. Mult Scler 21(2):163\u2013170","journal-title":"Mult Scler"},{"issue":"12","key":"11474_CR38","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1177\/1352458511418630","volume":"17","author":"S Saidha","year":"2011","unstructured":"Saidha S et al (2011) Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness. Mult Scler 17(12):1449\u20131463","journal-title":"Mult Scler"},{"issue":"2","key":"11474_CR39","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1093\/brain\/awr264","volume":"135","author":"SB Syc","year":"2012","unstructured":"Syc SB et al (2012) Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis. Brain 135(2):521\u2013533","journal-title":"Brain"},{"issue":"3","key":"11474_CR40","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1177\/1352458514564491","volume":"21","author":"RA Marrie","year":"2015","unstructured":"Marrie RA et al (2015) A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview. Mult Scler 21(3):263\u2013281","journal-title":"Mult Scler"},{"issue":"1","key":"11474_CR41","first-page":"93","volume":"87","author":"N De Stefano","year":"2016","unstructured":"De Stefano N et al (2016) Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis. J Neurol Neurosurg Psychiatry 87(1):93\u201399","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"11474_CR42","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1001\/jamaneurol.2018.1596","volume":"75","author":"M Andorra","year":"2018","unstructured":"Andorra M et al (2018) Assessing biological and methodological aspects of brain volume loss in multiple sclerosis. JAMA Neurol 75(10):1246\u20131255","journal-title":"JAMA Neurol"},{"issue":"1\u20132","key":"11474_CR43","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jns.2014.06.031","volume":"344","author":"LJ Balk","year":"2014","unstructured":"Balk LJ et al (2014) Physiological variation of retinal layer thickness is not caused by hydration: a randomised trial. J Neurol Sci 344(1\u20132):88\u201393","journal-title":"J Neurol Sci"},{"issue":"7","key":"11474_CR44","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1177\/1352458510371640","volume":"16","author":"SB Syc","year":"2010","unstructured":"Syc SB et al (2010) Reproducibility of high-resolution optical coherence tomography in multiple sclerosis. Mult Scler 16(7):829\u2013839","journal-title":"Mult Scler"},{"issue":"9","key":"11474_CR45","doi-asserted-by":"publisher","first-page":"5912","DOI":"10.1167\/iovs.11-8644","volume":"53","author":"L Pierro","year":"2012","unstructured":"Pierro L et al (2012) Retinal nerve fiber layer thickness reproducibility using seven different OCT instruments. Invest Ophthalmol Vis Sci 53(9):5912","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"11474_CR46","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000449","volume":"5","author":"T Oberwahrenbrock","year":"2018","unstructured":"Oberwahrenbrock T et al (2018) Multicenter reliability of semiautomatic retinal layer segmentation using OCT. Neurol Neuroimmunol Neuroinflamm 5(3):e449","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"12","key":"11474_CR47","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1002\/acn3.51473","volume":"8","author":"F Paul","year":"2021","unstructured":"Paul F et al (2021) Optical coherence tomography in multiple sclerosis: a 3-year prospective multicenter study. Ann Clin Transl Neurol 8(12):2235\u20132251","journal-title":"Ann Clin Transl Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11474-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-022-11474-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11474-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T10:04:36Z","timestamp":1675245876000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-022-11474-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,13]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["11474"],"URL":"https:\/\/doi.org\/10.1007\/s00415-022-11474-4","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,13]]},"assertion":[{"value":"5 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}